Patient Leaflet Updated 16-Jul-2025 | Vertex Pharmaceuticals (Europe) Limited
Kaftrio 60 mg / 40 mg / 80 mg and 75 mg / 50 mg / 100 mg Granules in Sachet
Kaftrio 60 mg/40 mg/80 mg granules in sachet
Kaftrio 75 mg/50 mg/100 mg granules in sachet
ivacaftor/tezacaftor/elexacaftor
1. What Kaftrio is and what it is used for
2. What you need to know before your child takes Kaftrio
3. How to take Kaftrio
4. Possible side effects
5. How to store Kaftrio
6. Contents of the pack and other information
Kaftrio contains three active substances: ivacaftor, tezacaftor and elexacaftor. The medicine helps lung cells to work better in some patients with cystic fibrosis (CF). CF is an inherited condition in which the lungs and the digestive system can become clogged with thick, sticky mucus.
Kaftrio taken with ivacaftor is for patients aged 2 to less than 6 years who have CF, with at least one F508del mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Kaftrio is intended as a long-term treatment.
Kaftrio works on a protein called CFTR. The protein is damaged in some people with CF, if they have a mutation in the CFTR gene.
Kaftrio is normally taken with another medicine, ivacaftor. Ivacaftor causes the protein to work better, while tezacaftor and elexacaftor increase the amount of protein at the cell surface.
Kaftrio (taken with ivacaftor) helps your child’s breathing by improving his/her lung function. You may also notice that your child does not get ill as often, or that it is easier for your child to gain weight.
Talk to your child’s doctor and do not give your child this medicine, if this applies to your child.
Tell your doctor right away if your child has any symptoms of liver problems. These are listed in section 4.
Do not give Kaftrio granules to children under the age of 2 years because it is not known if Kaftrio granules are safe and effective in this age group.
Tell your child’s doctor or pharmacist if your child is taking, has recently taken, or might take any other medicines. Some medicines can affect how Kaftrio works or may make side effects more likely. In particular, tell your child’s doctor if you take any of the medicines listed below. Your child’s doctor may change the dose of one of the medicines if your child takes any of these.
Avoid giving your child food or drinks containing grapefruit during treatment as these may increase the side effects of Kaftrio by increasing the amount of Kaftrio in your child’s body.
Kaftrio can make your child dizzy. If your child feels dizzy, it is advised that your child does not ride his/her bike or do anything else that needs his/her full attention.
If you have been told by your child’s doctor that your child has an intolerance to some sugars, contact your child’s doctor before your child takes this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially “sodium-free”.
Always give your child this medicine exactly as your child’s doctor or pharmacist has told you. Check with your child’s doctor or pharmacist if you are not sure.
Your child’s doctor will determine the correct dose for your child. Your child must keep using all other medicines, unless your child’s doctor tells him/her to stop using any.
Kaftrio is usually taken with ivacaftor.
Recommended dose for patients aged 2 to less than 6 years
Age - 2 to less than 6 years, Weight - <14 kg, Morning dose - One sachet of ivacaftor 60 mg/tezacaftor 40 mg/elexacaftor 80 mg granules, Evening dose - One sachet of ivacaftor 59.5 mg granules.
Age - 2 to less than 6 years, Weight - ≥14 kg, Morning dose - One sachet of ivacaftor 75 mg/tezacaftor 50 mg/elexacaftor 100 mg granules, Evening dose - One sachet of ivacaftor 75 mg granules
Give your child the morning and evening doses about 12 hours apart.
The granules are for oral use.
After mixing, give Kaftrio within 1 hour. Make sure all the medicine is taken.
Give both Kaftrio and ivacaftor doses with food that contains fat. Meals or snacks that contain fat include those prepared with butter or oils or those containing eggs. Other fat-containing foods are:
Avoid giving your child food and drink containing grapefruit while your child is taking Kaftrio. See Kaftrio with food and drink in section 2 for more details.
If your child has liver problems, either moderate or severe, your child’s doctor may reduce the dose of your child’s medicine or decide to stop treatment with Kaftrio. See also Warnings and precautions in section 2.
Contact your child’s doctor or pharmacist for advice. If possible, take your child’s medicine and this leaflet with you. Your child may get side effects, including those mentioned in section 4 below.
If you forget to give your child a dose, work out how long it is since the missed dose.
Do not give a double dose to make up for any missed doses.
Give Kaftrio to your child for as long as your child’s doctor recommends. Do not stop unless your child’s doctor advises you to.
If you have any further questions on the use of this medicine, ask your child’s doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible signs of liver problems
Liver damage and worsening of liver function in people with severe liver disease. The worsening of liver function can be serious and may require transplantation.
Increased liver enzymes in the blood are very common in patients treated with Kaftrio. These may be signs of liver problems:
Tell your child’s doctor straight away if he/she have any of these symptoms.
Very common side effects (may affect more than 1 in 10 people)
Tell your child’s doctor straight away if you notice a rash.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Side effects in adolescents are similar to those observed in adults.
If your child gets any side effects, talk to your child’s doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the:
or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton and on the blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your child’s pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Kaftrio 60 mg/40 mg/80 mg granules
Each sachet contains 60 mg of ivacaftor, 40 mg of tezacaftor and 80 mg elexacaftor.
Kaftrio 75 mg/50 mg/100 mg granules
Each sachet contains 75 mg of ivacaftor, 50 mg of tezacaftor and 100 mg elexacaftor.
See the end of section 2 for important information about the contents of Kaftrio.
Kaftrio 60 mg/40 mg/80 mg granules are white to off-white, granules in a sealed sachet.
Kaftrio 75 mg/50 mg/100 mg granules are white to off-white, granules in a sealed sachet.
Kaftrio is available in pack size of 28 sachets (4 weekly wallets, each with 7 sachets).
This leaflet was last revised in May 2025
Other sources of information
Detailed information on this medicine is available on the website of Medicines and Healthcare products Regulatory Agency: http://www.mhra.gov.uk.
2 Kingdom Street, London, W2 6BD, UK
0800 028 2616
0800 028 2616